CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 686	$ 315
Accounts receivable, net of allowance for credit losses of $27 and $30 as of December 31, 2023 and 2022, respectively	1,210	1,195
Inventories	190	192
Prepaid expenses and other current assets	286	196
Total current assets	2,372	1,898
Property, plant and equipment, net	1,816	1,766
Operating lease right-of-use assets	602	585
Goodwill	7,733	7,220
Intangible assets, net	1,166	1,092
Investments in equity method investees	135	132
Other assets	198	144
Total assets	14,022	12,837
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	1,359	1,396
Less: Current portion of long-term debt	303	2
Current portion of long-term operating lease liabilities	153	153
Total current liabilities	1,815	1,551
Long-term debt	4,410	3,978
Long-term operating lease liabilities	503	489
Other liabilities	876	812
Commitments and contingencies
Redeemable noncontrolling interest	76	77
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2023 and 2022; 162 shares issued as of both December 31, 2023 and 2022	2	2
Additional paid-in capital	2,320	2,295
Retained earnings	8,825	8,290
Accumulated other comprehensive (loss) income	(14)	(21)
Treasury stock, at cost; 51 shares as of both December 31, 2023 and 2022	(4,826)	(4,673)
Total Quest Diagnostics stockholders' equity	6,307	5,893
Noncontrolling interests	35	37
Total stockholders' equity	6,342	5,930
Total liabilities and stockholders' equity	$ 14,022	$ 12,837
Common stock, shares issued	162	162